Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Andrea K. Tarbox, a director at Solo Brands, Inc. (NYSE: SBDS), acquired 2,211 shares of Class A common stock on March 30, 2026, for about $9,000, according to a Form 4 filing. The transaction occurred at a weighted average price of $4.0707 per share, with individual trade prices between $3.725 and $4.29. The stock is trading below the purchase pri…
Immunome Inc. President and CEO Clay B. Siegall purchased 25,450 shares of common stock on March 27, 2026, for a total of $500,601, according to a Form 4 filing. The transaction follows a 187% year-over-year stock increase and comes as H.C. Wainwright begins coverage with a Buy rating and a $40 price target.
Navan, Inc. director Williams Anre D purchased 100,000 Class A shares on March 30, 2026, at $12.00 per share for $1.2 million. The transaction follows a recent 41% one-week rally although the stock is still down 40% over six months. Navan reported robust fourth-quarter results with $177.9 million in revenue, a 35% year-over-year increase, and achie…
Photronics Inc. (NASDAQ: PLAB) director Lee Kang Jyh sold 5,000 shares on March 26, 2026, for $40.8 each, generating $204,000, and on the same day exercised options to purchase 5,000 shares at $10.75 per share for $53,750. After the transactions he directly holds 385,850 shares. The company reported fiscal Q1 2026 results that topped analyst estima…
Impact Biomedical Inc. CFO Todd D. Macko sold 45,000 shares of common stock in two trades on March 25 and March 27, 2026, raising $25,330. The sales were executed at prices between $0.5615 and $0.6008. After the transactions Macko directly holds 155,122 shares. The stock trades at $0.59 and is up 15.92% year-to-date, while InvestingPro assessment i…
Control Empresarial de Capitales S.A. de C.V., a 10% holder of Talos Energy Inc., sold 2,312,000 common shares on March 26-27, 2026, raising $38,539,950. The two transactions occurred at weighted average prices of $16.6545 and $16.6802, respectively. After the sales the investor still holds 41,233,604 shares. The share sales coincide with Talos tra…
Director Leonard Tannenbaum bought 24,029 shares of Advanced Flower Capital Inc. (AFCG) on March 26 and 27, 2026, paying $2.60 per share for a total of $62,475. The transactions raised his direct holdings to 6,397,135 shares. The purchase comes amid a recent quarterly earnings miss and a stock trading near $2.64, roughly 50% below its level a year …
PBF Energy Senior Vice President Paul T. Davis sold 50,000 shares of Class A common stock on March 27, 2026, for $51.4836 per share, generating $2.57 million. The transaction followed the exercise of 50,000 options granted in 2017 at $28.67 per share. PBF’s recent quarter delivered an adjusted EPS of $0.66 versus an expected -$0.20, while revenue o…
22NW Fund, LP and related parties sold 12,717 shares of L.B. Foster Company (FSTR) between March 26 and March 30, 2026, for a total of $328,300. The shares changed hands at prices narrowly above the quoted $27.89 share price. After the disposals the group still indirectly controls 1,067,186 shares. Separately, L.B. Foster reported mixed fourth-quar…
Constellation Software Inc., together with Constellation Canadian Holdings Inc. and Mark Miller, acquired 10,634,702 shares of Sabre Corp common stock on February 27, 2026, at a weighted average price of $1.1605 for a total of about $12.3 million. The transaction increases Constellation Holdings' direct stake to 50,157,523 shares as Sabre navigates…
Datacentrex, Inc. director Allan Thomas Evans purchased 50,000 common shares on March 26, 2026, at $2.00 per share for $100,000. The stock trades at $2.19, though it has fallen 47% over six months. The company has priced a public offering expected to raise $20.17 million and filed SEC disclosures following its acquisition of Dogehash Technologies.
Robert P. Badavas, a director at Hercules Capital, purchased 3,658 shares on March 26, 2026, by electing stock in lieu of cash compensation. The transaction totaled $52,492 at an average $14.35 per share. The purchase comes while HTGC shares trade near a 52-week low and after a preliminary NAV improvement; the company is also navigating an amended …
Hercules Capital director Loo Wade purchased 7,317 shares of HTGC on March 26, 2026, paying an average of $14.35 per share for a total of $104,998. The buy came while the stock traded near a 52-week low and follows company disclosures of a modest NAV increase and new conditional financing activity. The firm also faces an analyst downgrade and a sho…
Entities tied to One Equity Partners completed two purchases of AdaptHealth Corp. (NASDAQ: AHCO) totaling $4.4 million. The acquisitions took place on March 19 and March 20, 2026, at prices between $9.81 and $9.95 per share. After the transactions, the reporting parties hold 16,312,698 shares. The trades come after AdaptHealth reported a significan…
A director of Hercules Capital, Inc. purchased 7,300 shares through a family trust, paying $14.30 per share for a total of $104,390 as the stock traded near its 52-week low. The transaction, executed in lieu of cash compensation, leaves the director with direct and indirect holdings. Hercules also released preliminary NAV estimates, amended a loan …
Jorey Chernett, listed as a 10% owner of Neuronetics, Inc. (NASDAQ: STIM), bought 385,442 shares of common stock on March 30, 2026, according to a Form 4 filing. The purchases, executed at prices between $1.23 and $1.26, totaled $481,802 at an average price of $1.25 per share. The move comes as the stock trades near $1.27 and close to its 52-week l…
Between March 10 and March 12, 2026, several related entities tied to One Equity Partners purchased a collective $19.9 million of AdaptHealth Corp. common stock at roughly $9.73 per share. The activity coincided with recent fourth-quarter 2025 results that showed a wide earnings shortfall but modest revenue outperformance and prompted mixed analyst…
Grocery Outlet Holding Corp. director Erik D. Ragatz acquired 125,000 shares on March 27, 2026, spending $882,500 at $7.06 per share. The transaction occurred while the stock traded near its 52-week low and after the company posted mixed fourth-quarter results that prompted several analyst price-target cuts and a downgrade.
Zevia PBC President and CEO Amy Taylor disposed of 144,008 Class A shares between March 26 and March 30, 2026, to meet tax liabilities tied to recently vested restricted stock units. The transactions occurred as Taylor also received more than 1 million shares from RSU vesting and after the company reported mixed fourth-quarter 2025 results and anno…
Walter R. Mayer, Senior Vice President and General Counsel of Battalion Oil Corp (BATL), sold 4,777 shares of common stock on March 27, 2026, for $6.00 per share, generating $28,662 in proceeds. The transaction leaves Mayer with 174 shares directly held. Battalion's share price has recently fallen from a prior close of $6.27 to $5.48, and the compa…
Castle Biosciences President and CEO Derek J. Maetzold sold 4,400 shares on March 26, 2026, for roughly $106,598 under a Rule 10b5-1 plan, while also exercising options for 550 shares. The company's stock has fallen since the sale, even as Castle posted stronger-than-expected fourth-quarter 2025 results and presented clinical data on its DecisionDx…
GitLab director Susan L. Bostrom sold 32,500 shares of Class A common stock on March 27, 2026, realizing roughly $661,700 in proceeds across two transactions. The trades occurred as the company's share price sits close to a 52-week low and follows quarterly results that beat consensus on several metrics but carried cautious fiscal 2027 revenue guid…
Granite Construction President and CEO Kyle T. Larkin sold 38,675 shares of company common stock on March 27 and March 30, 2026, under a pre-established Rule 10b5-1 trading plan. The transactions totaled $4,548,597 and were executed at prices between $115.716 and $119.188. The moves come as the stock trades near $116.49 and follow a strong fourth-q…
Olivier Bron, CEO of Bloomingdale's and an executive at Macy's Inc., sold 4,712 shares of Macy's common stock on March 27, 2026, for roughly $84,406. The transaction comes alongside a zero-valued acquisition of 11,035 shares the prior day, a new restricted stock unit grant, and a tax-related surrender of shares tied to performance awards. The stock…
Macy’s Executive Vice President and Chief HR Officer, Danielle L. Kirgan, sold 15,415 shares on March 27, 2026, for about $276,125, at prices between $17.8350 and $18.0500. The transactions follow a March 26 Form 4 showing both a zero-value acquisition of 46,789 shares and the disposition of 2,114 shares to cover taxes. Kirgan was also granted 48,6…
